SCHEMBL25015145

SCHEMBL25015145

CC(=O)OCCSc1ccc(C#Cc2ccc(OCc3ccc(C#C[Si](C)(C)C)cc3)c(C)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 6/20 0.38
PPARA Q07869 3/20 0.38
ACACB O00763 3/20 0.37
MRGPRX4 Q96LA9 2/20 0.37
FFAR4 Q5NUL3 3/20 0.36
GABRA1 P14867 4/20 0.34
GABRA5 P31644 4/20 0.34
GABRG2 P18507 3/20 0.34
GABRB3 P28472 3/20 0.34
GABRA3 P34903 3/20 0.34
GABRA2 P47869 3/20 0.34
GABRA6 Q16445 3/20 0.34
GABRA4 P48169 2/20 0.34
GABRB2 P47870 1/20 0.34
PPARG P37231 1/20 0.33
FFAR1 O14842 1/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015146 0.89 PPARD (0.40) PPARDPPARAACACBMRGPRX4FFAR4
SCHEMBL25015143 0.88 PPARA (0.41) PPARDPPARAACACBMRGPRX4FFAR4
SCHEMBL25015308 0.82 GABRA1 (0.35) ACACBGABRA1GABRA5GABRG2GABRB3
SCHEMBL25015302 0.81 PPARD (0.42) PPARDPPARAACACBMRGPRX4FFAR4
SCHEMBL24802693 0.80 FFAR4 (0.46) ACACBMRGPRX4FFAR4FFAR1RXRA
SCHEMBL24802637 0.76 FFAR4 (0.42) ACACBMRGPRX4FFAR4FFAR1RXRA
SCHEMBL25015144 0.76 FFAR1 (0.35) PPARDPPARAACACBFFAR1
SCHEMBL25015299 0.73 MAOB (0.43) PPARAACACBPPARG
SCHEMBL43368 0.72 ALDH1A1 (0.51) ACACBFFAR4GABRA1GABRA5GABRG2
SCHEMBL25015136 0.72 ACACB (0.43) PPARDPPARAACACBMRGPRX4FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230042009-A1 COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT FUJIFILM CORPORATION (JP) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230042009-A1 COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT SP1, C5, ZYX PPARD 4531/4885PPARA 3308/4885ACACB 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.